1Thomas JA, Marks BH. Plasma norepinephrine in congestive heart failure[J].Am J Cardiol, 1978;41:233-243.
2Packer M. Beta-adrenergic blockade in chronic heart failure: Principles, progress, and practice[J].Prog Cardiovasc Dis,1998,41(1 Suppl l ):39-46.
3Bristow MR, Herschberger RE,Port JD, et al.(Beta)-adrenergic pathways in the nonfailing and failing human ventricular myocardium[J].Circulation,1990,82(supp 3):112-125.
4Bristow MR, Minobe W, Rasnussen R, et al. Alpha1-adrenergic receptors in the nonfailing and failing human heart[J].J Pharmacol Exp Ther,1998,247:1039-1045.
5Knowlton KU ,Michel MC,Itani M, et al.The alpha1A-adrenergic receptor subtype mediates biochemical, molecular, and morphologic features of cultured myocardial cell hypertrophy[J].J Biol Chem,1993,268:15374-15380.
6Lechat PP. Meta-analysis of randomized clinical trials on beta-blocker treatment in heart failure (abstract)[J].Circulation,1996;94(suppl 1):1665.
